The Pathologic Effect of a Novel Neomorphic Fgf9Y162C Allele Is Restricted to Decreased Vision and Retarded Lens Growth
Author Information
Author(s): Puk Oliver, Möller Gabriele, Geerlof Arie, Krowiorz Kathrin, Ahmad Nafees, Wagner Sibylle, Adamski Jerzy, de Angelis Martin Hrabé, Graw Jochen
Primary Institution: Helmholtz Center Munich, German Research Center for Environmental Health
Hypothesis
The study aims to characterize the genetic and phenotypic effects of a novel Fgf9 allele associated with eye size abnormalities.
Conclusion
The Fgf9Y162C allele causes reduced vision and lens growth without affecting other organs or tissues.
Supporting Evidence
- The Fgf9Y162C allele was identified through a dominant ENU mutagenesis screen.
- Histological analysis showed that lens growth retardation starts during embryogenesis.
- Vision tests indicated a gene-dosage dependent vision loss of almost 50% in Fgf9Y162C mutants.
- Electroretinography revealed normal retinal function despite reduced vision.
- Fgf9Y162C carriers were fully viable and did not show skeletal malformations.
Takeaway
Scientists found a new gene change that makes mice have smaller lenses and worse vision, but it doesn't hurt other parts of their bodies.
Methodology
The study involved creating a mouse mutant line through ENU mutagenesis, followed by genetic and phenotypic characterization, including vision tests and lens growth measurements.
Limitations
The study primarily focuses on ocular effects and does not explore potential systemic impacts of the Fgf9Y162C allele.
Participant Demographics
The study used a mouse model, specifically the C57BL/6J strain.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website